Aeglea BioTherapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (30)

View All

Latest Posts

About This Stock More About This Stock
Aeglea BioTherapeutics Prices Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, June 6, 2017 11:28 AM EDT
Aeglea BioTherapeutics, Inc., today announced the pricing of its underwritten public offering of 3,000,000 shares of common stock at a public offering price of $4.10 per share, with expected gross proceeds to Aeglea of $12.3 million.
In this article: AGLE
Read
Aeglea BioTherapeutics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, June 5, 2017 5:02 PM EDT
Aeglea BioTherapeutics, Inc., today announced that it has commenced an underwritten public offering of common stock.
In this article: AGLE
Read
Aeglea Biotherapeutics IPO: Wait For Larger April Deals
Article By: Don Dion
Monday, April 4, 2016 10:39 PM EDT
Aeglea Biotherapeutics Inc. expects to raise $51.4 million in its upcoming IPO. Based in Austin, Texas, Aeglea Biotherapeutics is a biotechnology company developing enzyme-based therapeutics to treat disorders of metabolism and cancer.
In this article: AGLE Also: AZN, BMY, JNJ, LLY, NVS, AMGN, CELG
Read
Premarket Biotech Digest 2016-03-29: ACAD Nuplazid Review, APRI Tumbles, PBYI Delays NDA Filing
Article By: KKD Healthcare Analytics
Tuesday, March 29, 2016 8:31 AM EDT
Daily premarket biotech digest
In this article: ACAD, ALDR, EGRX, AXSM, BPMX, PBYI, AERI, APRI, AGLE
Read
All Posts

Latest Tweets for $AGLE

No tweets yet!

PARTNER HEADLINES